This document contains the preliminary scientific programme for the 12th European Congress of Internal Medicine taking place from October 2-5, 2013 in Prague, Czech Republic.
The programme includes sessions on various topics in internal medicine like cardiology, rheumatology, endocrinology, nephrology, infectious diseases, and hypertension. There will be opportunities to attend free paper communication sessions as well as joint sessions with other medical organizations.
The preliminary schedule provides details on session topics and speakers for each day of the conference in the Congress Hall and other venue halls. Registration is available each day from 8-9am and there are coffee breaks scheduled throughout each day. The opening ceremony is on October 3rd and the closing ceremony on
CME accredited Cardiologists 2019 to be held in Rome, Italy from June 17-19, 2019 is attracting more attendees to present their works and discuss their views. At the same time, they can plan a tour for visiting the historic city of Rome.
20th European Cardiology Conference (Euro Cardiology 2017): Scientific Programeuroheartfailure
The Cardiology Conference is proud to announce that its 3 day CME Accredited 20th European Cardiology Conference (Euro Cardiology 2017) will be held in Budapest, Hungary during October 16-18, 2017.
The conference will be the world’s best platform for all the cardiologists, cardiac surgeons, medical practitioners, research scholars and clinical research organizations to encourage and explore the modern technologies in the eternal field of Cardiology.
The main theme of the conference is “Invent the future of Cardiac Health”.
“Euro Cardiology 2016 was held in Madrid and will be remembered as one of the most fruitful experience attending this exciting Cardiology Event.” said Marco Picichè, San Camillo-Forlanini Hospital, Rome, Italy. “At the time, we received enthusiastic reviews from delegates about the record number of Hot Lines, scientific sessions and new formats which allowed more delegate interaction than ever before. We now look forward to even greater success in this year’s 20th European Cardiology Conference which is scheduled at Budapest, Hungary during October 16-18, 2017.”
Budapest is cited as one of the most beautiful cities in Europe ranked as the most liveable Central and Eastern European city on EIU's quality of life index ranked as "the world's second best city" by Condé Nast Traveller and "Europe's 7th most idyllic place to live" by Forbes. Budapest is one of the largest cities in the European Union and sometimes described as the primate city of Hungary. It became a single city occupying both banks of the Danube River with the unification of Buda and Óbuda on the west bank, with Pest on the east bank on November 17, 1873. It is an Alpha- global city with strengths in the healthcare, research, education, media, commerce, design, and tourism.
All these factors attract us to keep our coming grand event in hotel Mercure Budapest Buda which can easily manage modern event-support facilities, high-speed communication and IT networks and quality hotel accommodations.
The event showcases on latest research fields like Coronary Heart Diseases, Interventional Cardiology, Clinical Cardiology, Cardiac Surgery, Cardiac Remodelling, Paediatric Cardiology, Cardiac Nursing and Case reports on Cardiology etc.
Contact:
Evelyn Jones
Program Manager
Euro Cardiology 2017
Email: eurocardiology@cardiologymeeting.com; eurocardiology@cardiologyconference.org
Final Program of 2nd International Conference on #Cardiovascular Medicine and #Cardiac Surgery to be held in London, UK during March 15-16, 2017. The conference provides speakers and delegates with the opportunity to consolidate their knowledge and understanding of the latest scientific advancements. Cardiovascular 2017 is known for being a collaborative forum to exchange ideas and network through the symposium, panel discussions, poster sessions, and opportunities for the companies to exhibit at our event.
Predavanja domaćih i stranih eksperata pružio mi je dobar repetitorij, a kroz brojne live zahvate prikazani su bili dosezi i ograničenja novih naprednih dijagnostičko-terapijskih metoda us diskurz o indikacijama, kontraindikacijama i komplikacijama
Presentación del Dr. Josep Redón i Mas, del Hospital Clínico Universitario de Valencia, durante la I Reunión de Denervación Renal de la Sección de Hemodinámica y Cardiología Intervencionista (SHCI) de la Sociedad Española de Cardiología (SEC), celebrada del 29 al 30 de enero de 2014.
Prof Luigi Angrisani - Final program Brussels April 2014Luigi Angrisani
Il programma integrale del convegno svoltosi a Brussels ad aprile 2014, al quale ha partecipato Luigi Angrisani, nominato l'anno scorso Presidente dell'IFSO.
CME accredited Cardiologists 2019 to be held in Rome, Italy from June 17-19, 2019 is attracting more attendees to present their works and discuss their views. At the same time, they can plan a tour for visiting the historic city of Rome.
20th European Cardiology Conference (Euro Cardiology 2017): Scientific Programeuroheartfailure
The Cardiology Conference is proud to announce that its 3 day CME Accredited 20th European Cardiology Conference (Euro Cardiology 2017) will be held in Budapest, Hungary during October 16-18, 2017.
The conference will be the world’s best platform for all the cardiologists, cardiac surgeons, medical practitioners, research scholars and clinical research organizations to encourage and explore the modern technologies in the eternal field of Cardiology.
The main theme of the conference is “Invent the future of Cardiac Health”.
“Euro Cardiology 2016 was held in Madrid and will be remembered as one of the most fruitful experience attending this exciting Cardiology Event.” said Marco Picichè, San Camillo-Forlanini Hospital, Rome, Italy. “At the time, we received enthusiastic reviews from delegates about the record number of Hot Lines, scientific sessions and new formats which allowed more delegate interaction than ever before. We now look forward to even greater success in this year’s 20th European Cardiology Conference which is scheduled at Budapest, Hungary during October 16-18, 2017.”
Budapest is cited as one of the most beautiful cities in Europe ranked as the most liveable Central and Eastern European city on EIU's quality of life index ranked as "the world's second best city" by Condé Nast Traveller and "Europe's 7th most idyllic place to live" by Forbes. Budapest is one of the largest cities in the European Union and sometimes described as the primate city of Hungary. It became a single city occupying both banks of the Danube River with the unification of Buda and Óbuda on the west bank, with Pest on the east bank on November 17, 1873. It is an Alpha- global city with strengths in the healthcare, research, education, media, commerce, design, and tourism.
All these factors attract us to keep our coming grand event in hotel Mercure Budapest Buda which can easily manage modern event-support facilities, high-speed communication and IT networks and quality hotel accommodations.
The event showcases on latest research fields like Coronary Heart Diseases, Interventional Cardiology, Clinical Cardiology, Cardiac Surgery, Cardiac Remodelling, Paediatric Cardiology, Cardiac Nursing and Case reports on Cardiology etc.
Contact:
Evelyn Jones
Program Manager
Euro Cardiology 2017
Email: eurocardiology@cardiologymeeting.com; eurocardiology@cardiologyconference.org
Final Program of 2nd International Conference on #Cardiovascular Medicine and #Cardiac Surgery to be held in London, UK during March 15-16, 2017. The conference provides speakers and delegates with the opportunity to consolidate their knowledge and understanding of the latest scientific advancements. Cardiovascular 2017 is known for being a collaborative forum to exchange ideas and network through the symposium, panel discussions, poster sessions, and opportunities for the companies to exhibit at our event.
Predavanja domaćih i stranih eksperata pružio mi je dobar repetitorij, a kroz brojne live zahvate prikazani su bili dosezi i ograničenja novih naprednih dijagnostičko-terapijskih metoda us diskurz o indikacijama, kontraindikacijama i komplikacijama
Presentación del Dr. Josep Redón i Mas, del Hospital Clínico Universitario de Valencia, durante la I Reunión de Denervación Renal de la Sección de Hemodinámica y Cardiología Intervencionista (SHCI) de la Sociedad Española de Cardiología (SEC), celebrada del 29 al 30 de enero de 2014.
Prof Luigi Angrisani - Final program Brussels April 2014Luigi Angrisani
Il programma integrale del convegno svoltosi a Brussels ad aprile 2014, al quale ha partecipato Luigi Angrisani, nominato l'anno scorso Presidente dell'IFSO.
Ethanol (CH3CH2OH), or beverage alcohol, is a two-carbon alcohol
that is rapidly distributed in the body and brain. Ethanol alters many
neurochemical systems and has rewarding and addictive properties. It
is the oldest recreational drug and likely contributes to more morbidity,
mortality, and public health costs than all illicit drugs combined. The
5th edition of the Diagnostic and Statistical Manual of Mental Disorders
(DSM-5) integrates alcohol abuse and alcohol dependence into a single
disorder called alcohol use disorder (AUD), with mild, moderate,
and severe subclassifications (American Psychiatric Association, 2013).
In the DSM-5, all types of substance abuse and dependence have been
combined into a single substance use disorder (SUD) on a continuum
from mild to severe. A diagnosis of AUD requires that at least two of
the 11 DSM-5 behaviors be present within a 12-month period (mild
AUD: 2–3 criteria; moderate AUD: 4–5 criteria; severe AUD: 6–11 criteria).
The four main behavioral effects of AUD are impaired control over
drinking, negative social consequences, risky use, and altered physiological
effects (tolerance, withdrawal). This chapter presents an overview
of the prevalence and harmful consequences of AUD in the U.S.,
the systemic nature of the disease, neurocircuitry and stages of AUD,
comorbidities, fetal alcohol spectrum disorders, genetic risk factors, and
pharmacotherapies for AUD.
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?bkling
Are you curious about what’s new in cervical cancer research or unsure what the findings mean? Join Dr. Emily Ko, a gynecologic oncologist at Penn Medicine, to learn about the latest updates from the Society of Gynecologic Oncology (SGO) 2024 Annual Meeting on Women’s Cancer. Dr. Ko will discuss what the research presented at the conference means for you and answer your questions about the new developments.
263778731218 Abortion Clinic /Pills In Harare ,sisternakatoto
263778731218 Abortion Clinic /Pills In Harare ,ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group of receptionists, nurses, and physicians have worked together as a teamof receptionists, nurses, and physicians have worked together as a team wwww.lisywomensclinic.co.za/
Prix Galien International 2024 Forum ProgramLevi Shapiro
June 20, 2024, Prix Galien International and Jerusalem Ethics Forum in ROME. Detailed agenda including panels:
- ADVANCES IN CARDIOLOGY: A NEW PARADIGM IS COMING
- WOMEN’S HEALTH: FERTILITY PRESERVATION
- WHAT’S NEW IN THE TREATMENT OF INFECTIOUS,
ONCOLOGICAL AND INFLAMMATORY SKIN DISEASES?
- ARTIFICIAL INTELLIGENCE AND ETHICS
- GENE THERAPY
- BEYOND BORDERS: GLOBAL INITIATIVES FOR DEMOCRATIZING LIFE SCIENCE TECHNOLOGIES AND PROMOTING ACCESS TO HEALTHCARE
- ETHICAL CHALLENGES IN LIFE SCIENCES
- Prix Galien International Awards Ceremony
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdfAnujkumaranit
Artificial intelligence (AI) refers to the simulation of human intelligence processes by machines, especially computer systems. It encompasses tasks such as learning, reasoning, problem-solving, perception, and language understanding. AI technologies are revolutionizing various fields, from healthcare to finance, by enabling machines to perform tasks that typically require human intelligence.
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...kevinkariuki227
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
Recomendações da OMS sobre cuidados maternos e neonatais para uma experiência pós-natal positiva.
Em consonância com os ODS – Objetivos do Desenvolvimento Sustentável e a Estratégia Global para a Saúde das Mulheres, Crianças e Adolescentes, e aplicando uma abordagem baseada nos direitos humanos, os esforços de cuidados pós-natais devem expandir-se para além da cobertura e da simples sobrevivência, de modo a incluir cuidados de qualidade.
Estas diretrizes visam melhorar a qualidade dos cuidados pós-natais essenciais e de rotina prestados às mulheres e aos recém-nascidos, com o objetivo final de melhorar a saúde e o bem-estar materno e neonatal.
Uma “experiência pós-natal positiva” é um resultado importante para todas as mulheres que dão à luz e para os seus recém-nascidos, estabelecendo as bases para a melhoria da saúde e do bem-estar a curto e longo prazo. Uma experiência pós-natal positiva é definida como aquela em que as mulheres, pessoas que gestam, os recém-nascidos, os casais, os pais, os cuidadores e as famílias recebem informação consistente, garantia e apoio de profissionais de saúde motivados; e onde um sistema de saúde flexível e com recursos reconheça as necessidades das mulheres e dos bebês e respeite o seu contexto cultural.
Estas diretrizes consolidadas apresentam algumas recomendações novas e já bem fundamentadas sobre cuidados pós-natais de rotina para mulheres e neonatos que recebem cuidados no pós-parto em unidades de saúde ou na comunidade, independentemente dos recursos disponíveis.
É fornecido um conjunto abrangente de recomendações para cuidados durante o período puerperal, com ênfase nos cuidados essenciais que todas as mulheres e recém-nascidos devem receber, e com a devida atenção à qualidade dos cuidados; isto é, a entrega e a experiência do cuidado recebido. Estas diretrizes atualizam e ampliam as recomendações da OMS de 2014 sobre cuidados pós-natais da mãe e do recém-nascido e complementam as atuais diretrizes da OMS sobre a gestão de complicações pós-natais.
O estabelecimento da amamentação e o manejo das principais intercorrências é contemplada.
Recomendamos muito.
Vamos discutir essas recomendações no nosso curso de pós-graduação em Aleitamento no Instituto Ciclos.
Esta publicação só está disponível em inglês até o momento.
Prof. Marcus Renato de Carvalho
www.agostodourado.com
These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract.
Learning objectives:
1. Enlist the non-respiratory functions of the respiratory tract
2. Briefly explain how these functions are carried out
3. Discuss the significance of dead space
4. Differentiate between minute ventilation and alveolar ventilation
5. Describe the cough and sneeze reflexes
Study Resources:
1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition
4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
EFIM 2013 Programme 8.8.2013
1. th European Congress
of Internal Medicine
(European Federation of Internal Medicine EFIM)
2–5 October, 2013 | Prague, Czech Republic
www.efim2013.org
t
12 E CCCCCC
Welcome to
Prague!
Preliminary Scientific
Programme
2. 12th
European Congress of Internal Medicine (European Federation of Internal Medicine EFIM)
2–5 October, 2013 | Prague, Czech Republic
12th
European Congress of Internal Medicine (European Federation of Internal Medicine EFIM)
2–5 October, 2013 | Prague, Czech Republic
2 3
PROGRAMME OVERVIEW
Wednesday 2nd
October 2013
CONGRESS HALL
09:00–16:00
REGISTRATION
16:00–17:30
Opportunities of Internal Medicine in Europe and in the USA
Opportunities of Internal Medicine I.
17:30–18:00 Coffee Break
18:00–19:30 Opening Ceremony
19:30–21:00
Welcome Reception
21:00–21:30
Thursday 3rd
October 2013 Thursday 3rd
October 2013
CONGRESS HALL PANORAMA HALL CLUB D CLUB E
08:00–09:00
REGISTRATION
REGISTRATION
08:00–09:00
09:00–10:00 Rheumatology Clinical Biochemistry Young Internists Assembly
Free Communication
Noninvasive Cardiology I.
09:00–10:00
10:00–11:00 Cardiology
Current trends
in Pharmacotherapy
of Internal diseases
Young Internists Assembly
Free Communication
Pneumology / Rare diseases
10:00–11:00
11:00–11:30 Coffee Break Coffee Break Coffee Break Coffee Break 11:00–11:30
11:30–12:30
New horizons in Lipid Lowering
Therapy
Rare diseases Young Internists Assembly
Free Communication
Gastroenterology / Nephrology
11:30–12:30
12:30–14:00
Satellite Symposium Zentiva
AT1-blockers in Hypertension
Lunch Break Lunch Break Lunch Break 12:30–14:00
14:00–15:00 Nephrology I.
Incidentalomas
in Endocrinology
Free Communication
Infectious diseases I.
Free Communication
Hypertension / Diabetes
Mellitus
14:00–15:00
15:00–16:00 Hot Topics in Hypertension I. Infectious disease
Free Communication
Various I.
Free Communication
Endocrinology
15:00–16:00
16:00–16:30 Coffee Break Coffee Break Coffee Break Coffee Break 16:00–16:30
16:30–17:30 Hot Topics in Internal Medicine Atherosclerosis
Free Communication
Various II.
Free Communication
Stroke
16:30–17:30
3. 12th
European Congress of Internal Medicine (European Federation of Internal Medicine EFIM)
2–5 October, 2013 | Prague, Czech Republic
12th
European Congress of Internal Medicine (European Federation of Internal Medicine EFIM)
2–5 October, 2013 | Prague, Czech Republic
4 5
Friday 4th
October 2013 Friday 4th
October 2013
CONGRESS HALL PANORAMA HALL MEETING HALL 1 CLUB E
08:00–09:00
REGISTRATION
(08:00–18:00)
REGISTRATION
(08:00–18:00)
08:00–09:00
09:00–10:00 Gastroenterology Residual Risk Rheumatology – Essential skills
in musculoskeletal examination:
A practical workshop
09:00–10:00
10:00–11:00 Diabetes mellitus Hot Topics in Hypertension II. 10:00–11:00
11:00–11:30 Coffee Break Coffee Break Coffee Break 11:00–11:30
11:30–12:30
Satellite Symposium Zentiva
Statin Therapy in CV diseases
Break
Free Communication
Rheumatology
11:30–12:30
12:30–13:00 Current trends in Internal
Medicine I.
Lunch Break
Free Communication
Various III. (12:30–13:30)
12:30–13:00
13:00–14:00 Anemia in Chronic Diseases Lunch Break (13:30–14:00) 13:00–14:00
14:00–15:00 Metabolic Syndrome and DMT2 7th
Young Internists Day
Free Communication
Aterosclerosis / Angiology
14:00–15:00
15:00–16:00 Nephrology II. 7th
Young Internists Day
Free Communication
Infectious diseases II.
15:00–16:00
16:00–16:30 Coffee Break Coffee Break Coffee Break 16:00–16:30
16:30–17:30 Pulmonary Hypertension 7th
Young Internists Day
Free Communication
Noninvasive Cardiology II.
16:30–17:30
17:30–18:30 7th
Young Internists Day
Free Communication
Haematology / Oncology
17:30–18:30
Saturday 5th
October 2013
PANORAMA HALL
08:00–09:00
REGISTRATION
(08:30–13:00)
09:00–10:00 Debate-CAD
10:00–11:00 Interventional Angiology
11:00–11:10 Coffee Break
11:10–11:30 Cardiometabolic Risk
11:30–12:30 Cardiometabolic Risk – Gender oriented
12:30–13:00 Closing Ceremony
4. 12th
European Congress of Internal Medicine (European Federation of Internal Medicine EFIM)
2–5 October, 2013 | Prague, Czech Republic
12th
European Congress of Internal Medicine (European Federation of Internal Medicine EFIM)
2–5 October, 2013 | Prague, Czech Republic
6 7
SCIENTIFIC PROGRAMME
Wednesday October 2, 2013
09:00–21:00 Registration Opening
Congress Hall
16:00–17:30 Opportunities of Internal Medicine in Europe and in the USA
Chairs: P. Conthe (Spain), M. Cooke (USA)
M. Cooke (USA) President of ACP:
Internal medicine and the revolution in health care delivery in the United
States
R. Pujol (Spain):
The role of internists in different setting through Europe
Opportunities of Internal Medicine
Chairs: M.D. Cappellini (Italy), W.O. Bauer (Switzerland)
J. G. Alegria (Spain):
Efficient clinical management in Internal Medicine: Measuring quality
of care in your IM unit
A. M. Baptista (Portugal):
Acute medicine: Internist in emergency room, directing and bedside
working with the patient
P. M. Schumm Draeger (Germany):
Chronic disease: A multidisciplinary approach, internist collaborating
with other specialties in chronic disease, the example of diabetes
17:30–18:00 Coffee Break
18:00–19:30 Opening Ceremony
19:30–21:30 Welcome Reception
Thursday October 3, 2013
08:00–17:30 Registration Opening
Congress Hall
09:00–10:00 EULAR/CRS/EFIM Joint Session – Rheumatology
Chairs: K. Pavelka (Czech Republic), E. Kucharz (Poland)
E. Kucharz (Poland):
Cardiovascular complications in RA
K. Pavelka (Czech Republic):
Axial spondylarthritis
J. Vencovsky (Czech Republic):
Myositis
10:00–11:00 ESC/CSC/EFIM Joint Session on Cardiology
Chairs: D. Wood (Great Britain), R. Ceska (Czech Republic)
D. Wood (Great Britain):
European guidelines – Prevention of CVD
J. Hradec (Czech Republic):
European guidelines – Heart failure
P. Widimsky (Czech Republic):
European guidelines – Myocardial Infarction
11:00–11:30 Coffee Break
11:30–12:30 New horizons in Lipid Lowering Therapy
Chairs: K. Parhofer (Germany), D. Sereni (France)
R. Ceska (Czech Republic):
Familial Hypercholesterolemia
K. Parhofer (Germany):
PCSK-9 and new directions of treatment of Hypercholesterolemia
M. Vrablik (Czech Republic):
Screening programmes for FH
12:30–14:00 Satellite Scientific Symposium Zentiva: Hypertension in 2013 –
to know what, to know how
Chair: J. Widimsky (Czech Republic)
P. Nilsson (Sweden):
New European guidelines on hypertension
A. Corsini (Italy):
AT1 receptor blockers, potential differences
J. Skoupa (Czech Republic):
High quality, state of art and affordable cardiovascular medication –
myth or reality?
Wednesday,October2
Wednesday,October2
Thursday,October3
Thursday,October3
Friday,October4
Friday,October4
Saturday,October5
Saturday,October5
5. 12th
European Congress of Internal Medicine (European Federation of Internal Medicine EFIM)
2–5 October, 2013 | Prague, Czech Republic
12th
European Congress of Internal Medicine (European Federation of Internal Medicine EFIM)
2–5 October, 2013 | Prague, Czech Republic
8 9
10:00–11:00 Current trends in Pharmacotherapy of Internal diseases
Chair: Z. Reiner (Croatia)
Z. Reiner (Croatia):
ESC/EAS Guidelines for the management of dyslipidaemias
D. Karetova (Czech Republic):
Deep vein thrombosis and anticoagulant therapy
11:00–11:30 Coffee Break
11:30–12:30 Rare diseases
Chairs: D. Germain (France), A. Linhart (Czech Republic)
D. Germain (France):
General overview of lysosomal storage diseases
A. Linhart (Czech Republic):
Fabry disease
V. Malinova (Czech Republic):
Gaucher disease
12:30–14:00 Lunch Break
14:00–15:00 Incidentalomas in Endocrinology
Chairs: M. Krsek (Czech Republic), M. Terzolo (Italy)
R. Paschke (Germany):
Thyroid incidentalomas (nodules)
M. Terzolo (Italy):
Adrenal incidentalomas
M. Krsek (Czech Republic):
Pituitary incidentalomas
15:00–16:00 Infectious disease
Chair: J. Garau (Spain), F. Ferreira (Portugal)
J. Garau (Spain):
Influenza
M. Colombo (Italy):
Viral hepatitis: Advances in hepatitis C therapy
L. Machala (Czech Republic):
Antiretroviral Therapy – Where are we now
16:00–16:30 Coffee Break
14:00–15:00 ERA-EDTA/CNS/EFIM Joint Session on Nephrology I.
New guidelines for the diagnosis and treatment of patients with
chronic kidney disease
Chairs: A. Wiecek (Poland), C. Wanner (Germany)
A. Wiecek (Poland):
Treatment of anemia in chronic kidney disease
I. Rychlik (Czech Republic):
Treatment of hypertension in chronic kidney disease
C. Wanner (Germany):
Treatment of dyslipidemia in chronic kidney disease
15:00–16:00 ESH/EFIM Joint Session – Hot Topics in Hypertension I.
Chairs: R. Cifkova (Czech Republic), P. Nilsson (Sweden)
G. S. Stergiou (Greece):
Home and ambulatory blood pressure monitoring
A. Januszewicz (Poland):
Obstructive sleep apnoea and hypertension
P. Nilsson (Sweden):
Hypertension in diabetes
16:00–16:30 Coffee Break
16:30–17:30 Hot Topics in Internal Medicine
Chairs: M.D. Cappellini (Italy), J.W.F. Elte (The Netherlands)
F. Mantero (Italy):
Primary aldosteronism – update
Ch. Davidson (Great Britain):
Atrial fibrillation
F. Bosch (The Netherlands):
The role of ultrasound in the acutely ill medical patient
Panorama Hall
09:00–10:00 EFLM/CSKB/EFIM Joint Session
Clinical Biochemistry – Laboratory Medicine and Internal Medicine
Chairs: I. Watson (Great Britain), T. Zima (Czech Republic)
T. Zima (Czech Republic):
Tumour markers – using in the general practice – screening, monitoring,
effectiveness
I. Watson (Great Britain):
As a Patient what should I expect from Point of Care Laboratory Testing?
J. Berg (Great Britain):
Pathology Harmony; a pragmatic and scientific approach to unfounded
variation in the clinical laboratory
Wednesday,October2
Wednesday,October2
Thursday,October3
Thursday,October3
Friday,October4
Friday,October4
Saturday,October5
Saturday,October5
6. 12th
European Congress of Internal Medicine (European Federation of Internal Medicine EFIM)
2–5 October, 2013 | Prague, Czech Republic
12th
European Congress of Internal Medicine (European Federation of Internal Medicine EFIM)
2–5 October, 2013 | Prague, Czech Republic
10 11
15:00–16:00 Various I. (Free Communication)
B. Roson Hernandez (Spain):
Wernicke-semi: Descriptive analysis of 542 cases with wernicke
encephalopathy in Spain
A . Levin (Israel):
Medical futility in Israel health care system 2013
L. Santos Pinheiro (Portugal):
Readmissions in internal medicine: epidemiology and determinants
J. Carlos Alves (Portugal):
Severe skin necrosis induced by warfarin
G. Nobre de Jesus (Portugal):
Clinical impact of blood cultures on an internal medicine department
R. Louro (Portugal):
Age-Adjusted charlson comorbility index: is it time to a review?
16:00–16:30 Coffee Break
16:30–17:30 Various II. (Free Communication)
A. Dima (Romania):
Anti-pseudo PCNA auto antibodies: clinical and biological correlates in
a single center cohort of 48 patients
N. Oz (Israel):
Comparison between 2010 and 2012 guidelines for risk estimation for VTE
in hospitalized medical patients
R. Gunathilake (Australia):
Mild hyponatremia is linked to cognitive deficits and increased risk of falls
P. Garcia Romero (Spain):
Clinical characteristics of patients hospitalized for hip fracture
J.A. Medina (Spain):
Safety issues in a general internal medicine ward. A retrospective
observational study in a University Teaching Hospital
A. Lopes (Portugal):
A rare cause of surgical abdomen
16:30–17:30 EFIM/IAS/EAS Session
100 years a er Anitschkow – What have we learned over the last century?
Chairs: L. Tokgozoglu (Turkey), M. Vrablik (Czech Republic)
M. Vrablik (Czech Republic):
Atherosclerosis – from Anitschkow to global risk assessment
L. Tokgozoglu (Turkey):
Subclinical atherosclerosis imaging
A. Zambon (Italy):
Current treatment of HLP/DLP
A. Corsini (Italy):
Future and experimental therapy of HLP/DLP
Club D
09:00–10:00 Young Internists Assembly
10:00–11:00 Young Internists Assembly
11:00–11:30 Coffee Break
11:30–12:30 Young Internists Assembly
12:30–14:00 Lunch Break
14:00–15:00 Infectious diseases I. (Free Communication)
A. Purcarea (France):
The neutrophil index – lymphocyte and its usefulness in the early
diagnosis of infection in elderly patients. Cohort Study.
S. Namani (Albania):
Predictors for neurological complications of bacterial meningitis in adults
in a limited-resource country
C.A. Soyler (Turkey):
Differentiation of acute decompansated heart failure and pneumonia
in emergency department
L. Adelino (Portugal):
The look of a HIV patient
J. Trindade Nave (Potugal):
Microbial isolates in blood cultures in an internal medicine department
G. Nobre de Jesus (Portugal):
Prevalence and antimicrobial resistances of pathogens isolated on urine
cultures on an Internal Medicine ward
Wednesday,October2
Wednesday,October2
Thursday,October3
Thursday,October3
Friday,October4
Friday,October4
Saturday,October5
Saturday,October5
7. 12th
European Congress of Internal Medicine (European Federation of Internal Medicine EFIM)
2–5 October, 2013 | Prague, Czech Republic
12th
European Congress of Internal Medicine (European Federation of Internal Medicine EFIM)
2–5 October, 2013 | Prague, Czech Republic
12 13
11:30–12:30 Gastroenterology / Nephrology (Free Communication)
A.P. Shchkotova (Russian Federation):
Endothelial dysfunction, liver functional tests and fibrosis in chronic liver
diseases
G. Lopez Larramona (Spain):
Nutritional Assessment with CONUT-Index and its relationship with bone
mineral density disorders in chronic liver disease of mixed etiology
M. Stoian (Romania):
Correlations between the activity level/grading of viral hepatitis
and alterations in lipid and glucose metabolisms
J. Ramalho (Portugal):
Liver biopsies – What goes against the new recommendations?
R. Oprita (Romania):
Clostridium Difficile – Associated diarrhea, a new challenge
A. Ticinesi (Italy):
New pharmacologic approach to patients with idiopathic calcium
nephrolithiasis and high uricosuria: febuxostat vs allopurinol.
A pilot study
12:30–14:00 Lunch Break
14:00–15:00 Hypertension / Diabetes Mellitus (Free Communication)
Y. Venevtseva (Russian Federation):
Digestive system dysfunction influence on Holter monitoring results
in adolescents and young men with mild arterial hypertension
M. Destro (Italy):
Hypertension treatment: does the awareness of patients really affect
the goal?
J. Vaclavik (Czech Republic):
Addition of Spironolactone in Patients with Resistant Arterial
Hypertension (ASPIRANT-EXT): a Randomized, Double-blind,
Placebo-controlled Trial
G. Gulli (Italy):
Effects of a standardized educational program on type-2-diabetes
management in Internal Medicine. The DIAMOND study
from the Scientific Society FADOI
V.V. Shchekotov (Russian Federation):
Assessment of cardiac rhythm variability in patients with orthostatic
disorders against the background of type 2 diabetes mellitus
M. Gonçalves (Portugal):
Lactic acidosis in patients under metformin therapy
Club E
09:00–10:00 Noninvasive Cardiology I. (Free Communication)
J. Plasek (Czech Republic):
Resistance to aspirin and clopidogrel in acute myocardial infarction
(REACT-MI trial): preliminary results
G.S. Gheorghe (Romania):
Comorbidities in the elderly with atrial fibrillation and the decision of oral
anticoagulation in the real Word
G. Vescovo (Italy):
Real-world management, clinical outcome and predictors
of thromboembolism during a one-year follow-up in patients with atrial
fibrillation: the ATA-AF study
F. Dentali (Italy):
Acute pulmonary embolism or exacerbation of COPD? A challenging
clinical dilemma: preliminary results of a large multicenter study
A. Casas Vara (Spain):
Prognostic factors in Heart Failure Elderly Patients
V.A. Kokorin (Russian Federation):
New possibilities of early differential diagnosis of acute myocardial
infarction with cardiac fatty acids binding protein
10:00–11:00 Pneumology / Rare diseases (Free Communication)
R. Nardi (Italy):
Complexity of patients with COPD, a challenge in Internal Medicine
Departments: the COMPLEXICO study from the Scientific Society FADOI
Y. Agapova (Russian Federation):
Features of protein fractions in serum during COPD exacerbation
and remission at different disease stages
I. Soares (Potugal):
Community-acquired pneumonia in an internal medicine service
S. Kinova (Slovakia):
Gastroenteropatic Neuroendocrine tumors: multidisciplinary approach
in therapy and influence of tailored therapy for prognosis of patiens
J. Milisenda (Spain):
Dermatomyositis presenting with severe subcutaneous edema. Five
additional cases and review of the literature
A.A. Zulfiqar (France):
Late-onset systemic lupus: Clinical and biological characteristics of a series
of 13 patients
11:00–11:30 Coffee Break
Wednesday,October2
Wednesday,October2
Thursday,October3
Thursday,October3
Friday,October4
Friday,October4
Saturday,October5
Saturday,October5
8. 12th
European Congress of Internal Medicine (European Federation of Internal Medicine EFIM)
2–5 October, 2013 | Prague, Czech Republic
12th
European Congress of Internal Medicine (European Federation of Internal Medicine EFIM)
2–5 October, 2013 | Prague, Czech Republic
14 15
Friday October 4, 2013
08:00–18:00 Registration Opening
Congress Hall
09:00–10:00 Gastroenterology
Chairs: S. Lindgren (Sweden), F. Bosch (The Netherlands)
S. Lindgren (Sweden):
Spectrum of autoimmune liver disease with particular emphasis
on over-lap syndromes
B. Moum (Norway):
Epidemiology of IBD (inflammatory bowel disease)
M. Lukas (Czech Republic):
Clostridium difficile infection – the current problem of a clinical
gastroenterology
10:00–11:00 Diabetes mellitus
Chairs: J.W.F. Elte (The Netherlands), J. Skrha (Czech Republic)
J. Skrha (Czech Republic):
Modern trends in the treatment of Type 2 diabetes
I. Tkac (Slovakia):
The role of diabetic environment and genetic background
in the development of cardiovascular disease in diabetes
J.W.F. Elte (The Netherlands):
Diabetes and the liver – chicken or egg?
11:00–11:30 Coffee Break
11:30–12:30 Satelite Scientific Symposium Zentiva: Prevention of CHD:
Complex approach and/or focused therapy?
Chair: R. Ceska (Czech Republic)
D. Wood (Great Britain):
The polypill concept
A. Zambon (Italy):
Statins – still space for different choices in the class ?
P. Ostadal (Czech Republic):
Statins in ACS
15:00–16:00 Endocrinology (Free Communication)
C. Carvalho (Portugal):
Thyroid dysfunction induced by drugs
F. Gunes (Turkey):
HFABP levels relationship carotid artery intima media thickness and role
as a diagnostic marker for atherosclerosis in patient With hypothyroidism
M. Proenca (Portugal):
Prognostic value of subclinical hyperthyroidism in an Internal Medicine
ward
R. Cardiga (Portugal):
Hyperglycaemia in acutely ill non-diabetics
A.M. Marra (Italy):
Cardiovascular Abnormalities in Congenital Adrenal Hyperplasia
P. Queirós (Portugal):
Acute pancreatitis and primary hyperparathyroidism – an infrequent
association
16:00–16:30 Coffee Break
16:30–17:30 Stroke (Free Communication)
P. C. Azevedo (Portugal):
Stroke in patients aged 18 to 50 years – a 2-year retrospective study
A. Weiss (Israel):
Systolic Blood pressure during the first day of stroke predicts short-term
functional status and long term mortality in elderly patiens
V. Gafarov (Russian Federation):
Low social support as predictor of long-term risk of stroke in female
population in Russia: MONICA-psychosocial epidemiological study
K. Tziomalos (Greece):
The prognostic significance of nonalcoholic fatty liver disease in patients
with acute ischemic stroke
S. Mondello (Italy):
Novel Sensitive Assay Improves Diagnostic Accuracy of Serum GFAP
for the Identification of Intracerebral Hemorrhage in Acute Stroke Patients
P. Astazi (Italy):
“ABCD” Score in transient ischemic attacks
Wednesday,October2
Wednesday,October2
Thursday,October3
Thursday,October3
Friday,October4
Friday,October4
Saturday,October5
Saturday,October5
9. 12th
European Congress of Internal Medicine (European Federation of Internal Medicine EFIM)
2–5 October, 2013 | Prague, Czech Republic
12th
European Congress of Internal Medicine (European Federation of Internal Medicine EFIM)
2–5 October, 2013 | Prague, Czech Republic
16 17
14:00–15:00 Metabolic Syndrome and DMT2
Chairs: D. Dicker (Israel), A. Elis (Israel)
D. Dicker (Israel):
Fatty Heart – A new cardiovascular risk factor for the metabolic patient?
E. Grossman (Israel):
Hypertension in the obese and metabolic patient, should we treat differently?
M. Rapoport (Israel):
Hyperglycemia management in patients admitting internal medicine
department – do we know how?
15:00–16:00 ERA-EDTA/ČNS/EFIM Joint Session on Nephrology II.
Targeted treatment in systemic diseases with renal involvement
Chairs: V. Tesar (Czech Republic), R. Jones (Great Britain)
R. Jones (Great Britain):
Rituximab in the treatment of glomerular disease (ANCA-associated
vasculitis, lupus nephritis, membranous nephropathy)
V. Tesar (Czech Republic):
Belimumab in systemic lupus erythematosus
R. Rysava (Czech Republic):
Eculizumab in hemolytic uremic syndrome
16:00–16:30 Coffee Break
16:30–17:30 Pulmonary Hypertension
Chairs: A. Torbicki (Poland), A. Linhart (Czech Republic)
P. Jansa (Czech Republic):
Screening and early diagnosis of pulmonary HT
A. Linhart (Czech Republic):
Echocardiography in the diagnosis of pulmonary HT
A. Torbicki (Poland):
Treatment of pulmonary HT
12:30–14:00 Current trends in Internal Medicine I.
Chairs: A. Mahr (France), J. Spinar (Czech Republic)
R.Ceska (Czech Republic):
Reduction of the global cardiovascular risk in everyday practice – VARO
A. Mahr (France):
Updates in the management of vasculitis
V. Kokorin (Russia):
New possibilities of early differential diagnosis of acute myocardial
infarction with cardiac fatty acid binding protein
J. Belohlavek (Czech Republic):
Hyperinvasive approach to out of hospital cardiac arrest
Panorama Hall
09:00–10:00 R3i/EFIM Joint Session
Residual Risk – What does it mean? How to influence it?
Chairs: J. CH. Fruchart (France), E. Shlyakhto (Russia)
J. CH. Fruchart (France):
R3i
R. Ceska (Czech Republic):
Non pharmacological treatment of children with metabolic syndrome
A. Zambon (Italy):
Pharmacological treatment of residual risk
10:00–11:00 ESH/EFIM Joint Session – Hot Topics in Hypertension II.
Chairs: E. Grossman (Israel), C. Farsang (Hungary)
R. Cifkova (Czech Republic):
Epidemiology of hypertension in Europe
C. Farsang (Hungary):
Resistant hypertension
J. Widimsky jr (Czech Republic):
Renal denervation
11:00–11:30 Coffee Break
11:30–13:00 BREAK
13:00–14:00 Anemia in Chronic Diseases
Chairs: A. Bourgarit (France), I. Bruckner (Romania)
M. Markova (Czech Republic):
Anemia – classification and clinical approach
A. Bourgarit (France):
Anemia in the elderly
D. Bartos (Romania):
Anemia and heart failure
Wednesday,October2
Wednesday,October2
Thursday,October3
Thursday,October3
Friday,October4
Friday,October4
Saturday,October5
Saturday,October5
10. 12th
European Congress of Internal Medicine (European Federation of Internal Medicine EFIM)
2–5 October, 2013 | Prague, Czech Republic
12th
European Congress of Internal Medicine (European Federation of Internal Medicine EFIM)
2–5 October, 2013 | Prague, Czech Republic
18 19
11:30–12:30 Rheumatology (Free Communication)
D. Predeteanu (Romania):
Optimising the treatment for rheumatoid arthritis
S. Retamozo (Spain):
How to predict the development of lymphoproliferative disease in primary
Sjogren syndrome: baseline predictors in 921 Spanish patients (GEAS-SS
Registry)
P.I. Doti (Spain):
Mortality prognostic factors of patients with systemic autoimmune
diseases admitted to an intensive care unit
C. Vitali (Italy):
Prevalence of fragility vertebral fractures in Internal Medicine,
un underestimated issue? The POINT study from the Scientific Society
FADOI
S. Retamozo (Spain):
Safety and usefulness of minimally-invasive biopsy of minor salivary
glands in Internal Medicine: searching for systemic infiltrative diseases
12:30–13:30 Various III. (Free Communication)
P. Legido (Spain):
Results of the introduction of a comprehensive health care model
for plurypathological patiens
R. Gonzalez Ferrer (Spain):
Predictors of mortality a er hip fracture
T. van der Veer (The Netherlands):
Citation analysis of the ‘big six’ journals in internal medicine
R. Haider (Ireland):
Obstructive Sleep Apnea (OSA) and Metabolic Cormorbidities
D. Nicolás (Spain):
Characteristics of antibiotic therapy prescription in an Emergency
Department of a tertiary hospitál
M.D. Tanriover (Turkey):
Measles In Adults: clinical syndrome and treatment strategies
13:30–14:00 Coffee Break
Meeting Hall 1
12:30–14:00 Lunch Break
7th
Young Internists Day
Chairs: C. Araujo (Portugal), J. Vaclavik (Czech Republic)
14:00–14:15 L. Bosanska (Germany):
Young Internists in Europe
14:15–14:30 C. Araujo (Portugal):
The EFIM Exchange Programme
14:30–16:00 Clinical Gymnasium – Interactive case presentations
Moderators: Ch. Davidson (Great Britain), S. Rigby (Great Britain),
L. Dagna (Italy)
Speakers: (not confirmed yet)
16:00–16:30 Coffee Break
16:30–16:45 D. Sereni (France):
The Foundation for the Development of Internal Medicine in Europe –
Opportunities for Young Internists
16:45–17:30 M. Westerman (The Netherlands):
Lecture: Mind the Gap: The transition to hospital consultant
17:30–18:30 Discussion Round: Internal Medicine Training – Fit for the future?
Moderators: F. Weidanz (United Kingdom)
Club E
09:00–11:00 Rheumatology – Essential skills in musculoskeletal examination:
A practical workshop
Chairs: H. Almoallim (Saudi Arabia), N. Janoudi (Saudi Arabia)
This workshop is designed for practicing clinicians dealing with patients
with arthritis. The audience will be trained on essential skills
in musculoskeletal (MSK) examination that help to diagnose arthritis
in hand, wrist and shoulder joints.
An approach to comprehensive history from patients with joints pain will
be presented in an interactive way. Competency skills in MSK examination
among clinicians will be discussed. A descriptive hand-out will be
distributed to all participants.
11:00–11:30 Coffee Break
Wednesday,October2
Wednesday,October2
Thursday,October3
Thursday,October3
Friday,October4
Friday,October4
Saturday,October5
Saturday,October5
11. 12th
European Congress of Internal Medicine (European Federation of Internal Medicine EFIM)
2–5 October, 2013 | Prague, Czech Republic
12th
European Congress of Internal Medicine (European Federation of Internal Medicine EFIM)
2–5 October, 2013 | Prague, Czech Republic
20 21
16:30–17:30 Noninvasive Cardiology II. (Free Communication)
A.M. Marra (Italy):
Chronic Heart Failure and coexisting Growth Hormone Deficiency are
associated with worse clinical status, cardiopulmonary performance,
and LV remodeling
R. Quiros Lopez (Spain):
Heart failure in Internal Medicine and Cardiology departments, what is
the difference?
R. Quiros Lopez (Spain):
Vital signs at admission and its prognostic implications in patients older
than 80 year surviving a heart failure hospitalization
J.C. Gomez Ruiz (Spain):
Vital signs at admission and its prognostic implications in patients older
than 80 year surviving a heart failure hospitalization.
Z. Monhart (Czech Republic):
Cardiovascular risk factors in patients with acute coronary syndromes
treated in non-academic hospitals – incidence and awareness
R. Maia (Portugal):
Pulmonary Hypertension in Heart Failure
17:30–18:30 Haematology / Oncology (Free Communication)
S. Frasson (Italy):
Which predictors of recurrent venous thromboembolism in cancer
patients? An analysis on 9280 cases from the worldwide RIETE registry
M. Correia (Portugal):
Venous thromboembolism and malignancy
A. Lopes Braz (Portugal):
The pain could be the sign of a serious pathology
P. Aranha (Portugal):
Congenital factor VII deficiency: bleeding-thrombosis dyad
O. Lopez Berastegui (Spain):
Anemia in older patients: An etiologic profile
L. Adelino (Portugal):
Ataxic gait and hearing loss in a patient with a history of mantle cell
lymphoma
14:00–15:00 Aterosclerosis / Angiology (Free Communication)
C. Mozzini (Italy):
Increased endoplasmic reticulum stress and Nrf2 repression in peripheral
blood mononuclear cells of patients with stable coronary artery disease
M.L. Morieri (Italy):
Low grade systemic inflammation and insulin resistance, instead
of metabolic syndrome, as predictors of 9-years mortality in older
population
C. Morcillo (Spain):
Prognosis of detection of silent coronary artery disease by computed
tomographic scan
O. Hussein (Israel):
The Antiatherogenic Properties of HDL in Psychiatric Patients
with and without Antipsychotic Therapy
A. Incze (Romania):
Effects of stem cell transplantation and intravenous prostaglandin therapy
in peripheral arterial disease of the elderly
J. Gutierrez Guisado (Spain):
Venous thromboembolism and minor injuries in lower extremity
15:00–16:00 Infectious diseases II. (Free Communication)
C. Cardozo (Spain):
Efficacy of taurolock® solution for preventiv catheter-related bacteriemia
(CRB)
A. L. Vieira (Portugal):
Appropriateness of antibiotic prescriptions for hospital emergency
department patiens
J. Melo Alves (Portugal):
A new look on Staphylococcus bloodstream infections
S. Frasson (Italy):
Venous thromboembolism in patients with acute infection and immobility:
findings from the international RIETE registry
N. Lareva (Russian Federation):
Risk factors of fatal outcomes in 2009 Pandemic influenza A (H1N1) viral
infection in Zabaikalsky region of Russian Federation
A. Ticinesi (Italy):
Carbapenemase-producing Klebsiella pneumoniae (KPC) infection
outbreak in Italy: report of an experience with elderly frail patients
16:00–16:30 Coffee Break
Wednesday,October2
Wednesday,October2
Thursday,October3
Thursday,October3
Friday,October4
Friday,October4
Saturday,October5
Saturday,October5
12. 12th
European Congress of Internal Medicine (European Federation of Internal Medicine EFIM)
2–5 October, 2013 | Prague, Czech Republic
12th
European Congress of Internal Medicine (European Federation of Internal Medicine EFIM)
2–5 October, 2013 | Prague, Czech Republic
22 23
Saturday October 5, 2013
08:30–13:00 Registration Opening
Panorama Hall
09:00–10:00 Current controversies debates
L. Kotik (Czech Republic) – T. Kovarnik (Czech Republic):
Conservative or invasive treatment of stable CAD?
10:00–11:00 Interventional Angiology
Chairs: V. Kokorin (Russia), M. Bulvas (Czech Republic)
S. Heller (Czech Republic):
Challenges in the endovascular treatment of AAA
V. Prochazka (Czech Republic):
Endovascular therapy of acute cerebral ischemia
M. Bulvas (Czech Republic):
Mechanical thrombo-embolectomy in acute and subacute ischemia
of lower limbs
11:00–11:10 Coffee Break
11:10–11:30 Cardiometabolic Risk
Chair: P. M. Schumm Draeger (Germany)
N. M. Lalic (Serbia):
An update on relevance for prevention and treatment of diabetes
11:30–12:30 Cardiometabolic Risk – Gender oriented
Chair: P. M. Schumm Draeger (Germany)
S. Oertelt Prigione (Germany):
Gender Differences in Incidence and Prevention of Cardiovascular
Diseases
P. M. Schumm Draeger (Germany):
Obesity, metabolic syndrome, Diabetes – are women at higher risk?
12:30–13:00 CLOSING CEREMONY
Wednesday,October2
Wednesday,October2
Thursday,October3
Thursday,October3
Friday,October4
Friday,October4
Saturday,October5
Saturday,October5
13. Congress Secretariat
GUARANT International spol. s r.o.
Na Pankráci 17, 140 21 Prague 4, Czech Republic
Tel: +420 284 001 444
E-mail: efim2013@guarant.cz
www.efim2013.org